Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Study Design

Type
Randomized Controlled Trial (RCT)
Population
healthy Japanese men and women aged 27-64 years
Methods
placebo-controlled randomized double-blind parallel-group study, 4 weeks of consuming 2.7 g of matcha daily
Blinding
Double-blind
Duration
4 weeks
Funding
Unclear
  • Rigorous Journal
Although theanine in matcha improves sleep quality and cognitive function, the caffeine in green tea is thought to worsen sleep quality. Therefore, this study investigated the factors behind the observed improvements in subjective sleep quality in matcha. A placebo-controlled randomized double-blind parallel-group study was conducted on healthy Japanese men and women aged 27-64 years. After 4 weeks of consuming 2.7 g of matcha daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine), no significant differences were observed between the control and matcha groups on total sleep time, sleep latency, wake after sleep onset, or sleep efficiency measured by electroencephalography (EEG). However, the sleep questionnaire Oguri-Shirakawa-Azumi Sleep Inventory, the Middle-age and Aged version (OSA-MA), administered immediately after waking showed a trend toward increased satisfaction with sleep time (p < 0.1), and EEG measurements indicated significantly shortened wake-up times after waking with matcha intake (p < 0.05). The Beck Depression Inventory-II scores also tended to decrease (p < 0.1). The continuous intake of matcha may offer improved subjective sleep quality and emotional stability despite not offering significant changes in objective sleep parameters.

Research Insights

  • no significant differences were observed between the control and matcha groups on ... sleep efficiency measured by electroencephalography (EEG)

    Effect
    Neutral
    Effect size
    Small
    Dose
    2.7 g daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine)
  • no significant differences were observed between the control and matcha groups on ... sleep latency

    Effect
    Neutral
    Effect size
    Small
    Dose
    2.7 g daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine)
  • the sleep questionnaire Oguri-Shirakawa-Azumi Sleep Inventory, the Middle-age and Aged version (OSA-MA), administered immediately after waking showed a trend toward increased satisfaction with sleep time (p < 0.1)

    Effect
    Neutral
    Effect size
    Small
    Dose
    2.7 g matcha daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine)
  • no significant differences were observed between the control and matcha groups on total sleep time

    Effect
    Neutral
    Effect size
    Small
    Dose
    2.7 g daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine)
  • the sleep questionnaire ... showed a trend toward increased satisfaction with sleep time (p < 0.1)

    Effect
    Neutral
    Effect size
    Small
    Dose
    2.7 g daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine)
  • no significant differences were observed between the control and matcha groups on total sleep time, sleep latency, wake after sleep onset, or sleep efficiency measured by electroencephalography (EEG)

    Effect
    Neutral
    Effect size
    Small
    Dose
    2.7 g matcha daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine)
  • The Beck Depression Inventory-II scores also tended to decrease (p < 0.1)

    Effect
    Neutral
    Effect size
    Small
    Dose
    2.7 g daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine)
  • no significant differences were observed between the control and matcha groups on total sleep time, sleep latency, wake after sleep onset, or sleep efficiency measured by electroencephalography (EEG)

    Effect
    Neutral
    Effect size
    Small
    Dose
    2.7 g matcha daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine)
  • EEG measurements indicated significantly shortened wake-up times after waking with matcha intake (p < 0.05)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    2.7 g daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine)
Back to top